Gender Differences in Aspirin use Among Adults With Coronary Heart Disease in the United States

[1] Ridker PM(1994)prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients Antiplatelet Trialists’ Collaboration. BMJ 308 81-06

[2] Cook NR(2005)A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women N Engl J Med 352 1293-1304

[3] Lee IM(2006)Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials JAMA 295 306-313

[4] Berger JS(2004)Evidence-based guidelines for cardiovascular disease prevention in women Circulation 109 672-693

[5] Roncaglioni MC(2001)AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology J Am Coll Cardiol 38 1581-1583

[6] Avanzini F(1996)Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly Arch Intern Med 156 799-805

[7] Pangrazzi I(1991)Differences in the use of procedures between women and men hospitalized for coronary heart disease N Engl J Med 325 221-225

[8] Tognoni G(2000)Acute myocardial infarction in women: contribution of treatment variables to adverse outcome Am Heart J 140 740-746

[9] Brown DL(1996)Gender differences and factors associated with the receipt of thrombolytic therapy in patients with acute myocardial infarction: a community-wide perspective Am Heart J 131 43-50

[10] Mosca L(2000)Race, sex, poverty, and the medical treatment of acute myocardial infarction in the elderly Circulation 102 642-648

[1] Ridker PM(1994)prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients Antiplatelet Trialists’ Collaboration. BMJ 308 81-06

[2] Cook NR(2005)A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women N Engl J Med 352 1293-1304

[3] Lee IM(2006)Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials JAMA 295 306-313

[4] Berger JS(2004)Evidence-based guidelines for cardiovascular disease prevention in women Circulation 109 672-693

[5] Roncaglioni MC(2001)AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology J Am Coll Cardiol 38 1581-1583

[6] Avanzini F(1996)Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly Arch Intern Med 156 799-805

[7] Pangrazzi I(1991)Differences in the use of procedures between women and men hospitalized for coronary heart disease N Engl J Med 325 221-225

[8] Tognoni G(2000)Acute myocardial infarction in women: contribution of treatment variables to adverse outcome Am Heart J 140 740-746

[9] Brown DL(1996)Gender differences and factors associated with the receipt of thrombolytic therapy in patients with acute myocardial infarction: a community-wide perspective Am Heart J 131 43-50

[10] Mosca L(2000)Race, sex, poverty, and the medical treatment of acute myocardial infarction in the elderly Circulation 102 642-648